Pfizer’s prostate cancer data leak shows promising results in early-stage study
Clinical trial results from a Phase 1 study by Pfizer leaked days before a late-breaking presentation scheduled for Thursday, showing that the drugmaker’s prostate cancer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.